Amneal Pharmaceuticals (NASDAQ: AMRX) STOCK RECOMMENDATION
Idea | BUY |
Buy Range | 8.5 – 8.75 |
Target | 9.1 – 9.25 |
StopLoss* | below 8.25 |
Duration | 10-12 Trading Days |
Potential Returns | 5% – 6% |
Idea | Buy Range | Target | StopLoss* | Duration | Potential Returns |
BUY | 8.5 – 8.75 | 9.1 – 9.25 | below 8.25 | 10-12 Trading Days | 5% – 6% |
* Once the first target hit, reset the StopLoss at your buying price.
Our recommendations are authentic and transparent. Find this recommendation posted in Tradingview. Be assured such records are permanent and irreversible.
Amneal Pharmaceuticals (NASDAQ: AMRX) STOCK OVERVIEW
Amneal Pharmaceuticals, Inc. and its subsidiaries develop, manufacture, market, and distribute generics, injectables, biosimilars, and specialty branded drugs globally. The company has three segments: Generics, Specialty, and AvKARE. The Generics segment provides various forms of medications, including oral solids, injectables, and topical products. The Specialty segment focuses on drugs for central nervous system and endocrine disorders, offering products like Rytary for Parkinsonโs disease and Unithroid for hypothyroidism. The AvKARE segment supplies pharmaceuticals and medical products mainly to government agencies and the Department of Defense, also distributing under the AvKARE and AvPAK brands. Products are sold through wholesalers, hospitals, and pharmacies. Founded in 2002 and based in Bridgewater, New Jersey, the company was previously known as Atlas Holdings, Inc. before rebranding in 2018.
ย
Stock Data | |
NASDAQ Symbol | AMRX |
Sectoral Index | Health Care |
52 Weeks High | 8.94 |
52 Weeks Low | 3.36 |
Amneal Pharmaceuticals (NASDAQ: AMRX) - RELATIVE STRENGTH

Relative Performance - Last 1 Year
AMRX — NASDAQ —
Amneal Pharmaceuticals (NASDAQ: AMRX) - DAILY TECHNICAL ANALYSIS

- The stock price has been increasing within a parallel channel and is exhibiting robust upward momentum.
- Previously, the price underwent a consolidation phase within a Rectangle pattern, and following a breakout, it surged to new levels.
- Currently, the price has established a Symmetrical Triangle pattern and is poised for a potential breakout in the near future.
Amneal Pharmaceuticals (NASDAQ: AMRX) - RSI

- Current RSI of this stock is 59.32, which indicates the strength of buyers.
Amneal Pharmaceuticals (NASDAQ: AMRX) - MACD

- MACD line is about to cross the signal line from the below, generates bullish signal.
Amneal Pharmaceuticals (NASDAQ: AMRX) - EMA CROSS

- The short length exponential moving average (10 EMA) has crossed the long length exponential moving average (20 EMA) from the below, generates bullish signal. Last dayโs candle has closed above all these moving averages. This suggests buyers are taking interest in this stock.
CONCLUSION - Amneal Pharmaceuticals (NASDAQ: AMRX) STOCK PRICE FORECAST
Based on our stock trading advice in USA, Amneal Pharmaceuticals stock price target will be USD 9.1 – USD 9.25 in the next 10-12 trading sessions.